SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Nath Bio-Genes

Nath Bio-Genes

BSE: 537291|NSE: NATHBIOGEN|ISIN: INE448G01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 26, 16:01
107.50
-0.5 (-0.46%)
VOLUME 2,593
LIVE
NSE
Aug 26, 16:01
107.80
1.2 (1.13%)
VOLUME 9,584

Quarterly Results of Nath Bio-Genes

------------------- in Rs. Cr. -------------------
Jun '16 Mar '16 Dec '15 Sep '15 Jun '15
Net Sales/Income from operations 84.33 28.29 23.32 3.95 106.55
Other Operating Income -- -- -- -- --
Total Income From Operations 84.33 28.29 23.32 3.95 106.55
EXPENDITURE
Consumption of Raw Materials 19.81 10.46 25.77 1.93 39.80
Purchase of Traded Goods -- -- -- -- --
Increase/Decrease in Stocks 17.65 -6.49 -18.58 0.56 0.10
Power & Fuel -- -- -- -- --
Employees Cost 4.44 2.14 3.03 3.55 4.92
Depreciation 1.00 -0.01 1.65 1.16 1.10
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 20.63 12.24 5.40 1.19 31.50
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 2.08 12.64 3.89 0.12 3.43
P/L Before Other Inc. , Int., Excpt. Items & Tax 18.72 -2.68 2.16 -4.56 25.70
Other Income 0.12 0.46 0.03 0.18 0.04
P/L Before Int., Excpt. Items & Tax 18.84 -2.22 2.19 -4.38 25.74
Interest 2.34 0.66 1.41 2.47 1.69
P/L Before Exceptional Items & Tax 16.49 -2.88 0.78 -6.85 24.04
Exceptional Items -- -- -- -- --
P/L Before Tax 16.49 -2.88 0.78 -6.85 24.04
Tax -- 0.71 0.20 -- --
P/L After Tax from Ordinary Activities 16.49 -3.59 0.58 -6.85 24.04
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- 0.00 0.00 -0.02 --
Net Profit/(Loss) For the Period 16.49 -3.59 0.58 -6.87 24.04
Equity Share Capital 16.00 16.00 16.00 16.00 16.00
Reserves Excluding Revaluation Reserves 121.79 105.30 108.89 108.31 115.18
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 10.31 -2.24 0.36 -4.29 15.02
Diluted EPS 10.31 -2.24 0.36 -4.29 15.02
EPS After Extra Ordinary
Basic EPS 10.31 -2.24 0.36 -4.29 15.02
Diluted EPS 10.31 -2.24 0.36 -4.29 15.02
Public Share Holding
No Of Shares (Crores) 0.78 0.78 0.88 0.88 0.84
Share Holding (%) 48.61 48.61 54.99 54.99 52.18
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) 0.67 0.59 0.44 0.44 0.44
- Per. of shares (as a % of the total sh. of prom. and promoter group) 81.04 71.98 61.36 61.36 57.76
- Per. of shares (as a % of the total Share Cap. of the company) 41.65 36.99 27.62 27.62 27.62
b) Non-encumbered
- Number of shares (Crores) 0.16 0.23 0.28 0.28 0.32
- Per. of shares (as a % of the total sh. of prom. and promoter group) 18.96 28.02 38.64 38.64 42.24
- Per. of shares (as a % of the total Share Cap. of the company) 9.74 14.40 17.39 17.39 20.20
Notes Notes To The Accounts
Source : Dion Global Solutions Limited

Results of Nath Bio-Genes

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for nathbiogenes
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.